4//SEC Filing
Pierce David A 4
Accession 0001225208-22-002932
CIK 0000885725other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:46 PM ET
Size
14.8 KB
Accession
0001225208-22-002932
Insider Transaction Report
Form 4
Pierce David A
SVP and President, Endoscopy
Transactions
- Exercise/Conversion
Deferred Stock Units
2022-02-18−2,668→ 5,337 totalExp: 2024-02-18→ Common Stock (2,668 underlying) - Exercise/Conversion
Common Stock
2022-02-17+3,333→ 3,333 total - Tax Payment
Common Stock
2022-02-17$42.83/sh−979$41,931→ 2,354 total - Exercise/Conversion
Common Stock
2022-02-18+2,668→ 5,022 total - Sale
Common Stock
2022-02-18$42.88/sh−2,354$100,940→ 1,884 total - Tax Payment
Common Stock
2022-02-18$42.55/sh−784$33,359→ 4,238 total - Exercise/Conversion
Restricted Stock Units
2022-02-17−3,333→ 10,000 totalExp: 2025-02-17→ Common Stock (3,333 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F3]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- [F5]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001529751
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:46 PM ET
- Size
- 14.8 KB